Global intravenous (IV) iron and oral iron market is expected to cross US$ 3 billion by 2021, growing at a CAGR of 5%.
Iron drugs are the supplements containing iron prescribed by a doctor to treat anemia or other iron deficiencies. Oral iron supplements are recommended to maintain the iron level in the body. However, in some cases, oral administrations are not capable of maintaining the iron level in the body and intravenous (IV) iron therapy comes into the picture.
Global Intravenous (IV) Iron and Oral Iron market research report covers the present scenario and the growth prospects of the iron drugs market for the period 2016-2021. The report provides in-depth market analysis of market size and growth of Global Intravenous (IV) Iron and Oral Iron market.
Scope of the Report:
This market research report categories the Global Intravenous (IV) Iron and Oral Iron market based on mode of delivery, therapeutic area and geography. This market research includes a detailed market segmentation of the worldwide Intravenous (IV) iron and oral market by
By Mode of Delivery
• Oral Iron
• Ferrous Sulfate
• Carbonyl Iron
• Intravenous (IV) Iron
• Iron Dextran Complex
• Iron Sucrose
• Ferric Carboxymaltose
By Therapeutic Area
• Nephrology
• Gynecology and Obstetrics
• Gastroenterology
• Oncology
• Chronic Heart Failures
• Patient Blood Management
By Geography
• Americas
• APAC
• EMEA
By Country
• Africa
• Brazil
• Canada
• China
• France
• Germany
• India
• Italy
• Japan
• Mexico
• Netherland
• New Zealand
• Spain
• Switzerland
• UK
• US
Global Intravenous (IV) Iron and Oral Iron Market - Market Size and Dynamics
Analysts at Beige Market Intelligence expects the global intravenous (IV) iron and oral iron market to cross US$ 3 billion by 2021, growing at an impressive CAGR close to 5%. Iron drugs are widely used in various therapeutic areas like nephrology, gynaecology, oncology, gastroenterology, surgeries, and chronic heart failures. This catalyses the growth of global intravenous (IV) iron and oral iron market. Furthermore, factors such as correction of IDA in pregnancy, growing diabetic population worldwide, growing incidence of Chronic Kidney Disease (CKD) that increases the need of dialysis, prevalence of iron deficiency are the major factors attributing to the growth of the market.
The global intravenous (IV) iron and oral iron market is majorly categorised into two categories as per there mode of delivery such as oral and intravenous (IV). The oral delivery of iron in form of tablets, capsules, syrups is the most economic medical treatment for iron deficiency anaemia. Ferrous sulfate is the most common and cheapest form of oral therapy for treating patients with iron deficiency anemia. Though oral iron drugs market size is expected to increase to a notable figure over next five years, it can lose significant amount of its market share to intravenous (IV) iron therapies in near future.
Intravenously iron is delivered to patients who are either unable to absorb oral iron or who has increasing anemia despite adequate doses of oral iron. Growing incidence of Chronic Kidney Disease (CKD), iron deficiency diseases related to gynecology, nephrology, gastroenterology, and oncology is driving growth of the intravenous iron therapy. The high growth rate of IV iron market can be attributed to the paradigm shift of healthcare providers/patients to IV iron therapies from oral iron therapies.
The research report provides a detailed analysis and growth forecast of each therapeutic area. Nephrology is the largest application area of the intravenous (IV) iron and oral iron drugs followed by Gynecology and Gastroenterology.
Global Intravenous (IV) Iron and Oral Iron - Trends, Drivers, and Challenges
The market research report on intravenous (IV) iron and oral iron market provides a comprehensive study about the factors affecting the market growth and upcoming challenges. The research report describes the growth driving factors of the global intravenous (IV) iron and oral iron market for the next five years. Increasing number of dialysis patients and growing diabetic population worldwide are among the major drivers described in the intravenous (IV) iron and oral iron market research report.
Paradigm shift from oral iron drugs to intravenous (IV) iron drugs is a major trend in the market. There are gastrointestinal side effects associated with oral iron drugs like nausea, constipation, anorexia, heartburn, vomiting, and diarrhea and are intolerant even by healthy patients. Thus the side effects of oral iron drugs has attracted the patients towards intravenous (IV) iron. Also with the increasing awareness of IDA during pregnancy and shift towards healthier lifestyle; correction of IDA in pregnant women is the current trend driving the market for oral and IV iron.
Today, the trend is driving towards focus on healthy diet, healthy lifestyle, adoption of healthy solutions to build health. Thus, intake of healthy diet and nutraceuticals is a blooming alternative for daily medication for nutrient deficiency like iron deficiency. Hence, focus on healthy diet and nutraceuticals is one of the major challenges included in the report
Global Intravenous (IV) Iron and Oral Iron - Key Market Growth Opportunities
The report outlines the major growth opportunities in global intravenous (IV) iron and oral iron market. It includes a detailed description of the opportunities for the year 2016-2021. Huge patient population undergoing dialysis and patient blood management are among the notable growth opportunities in the global intravenous (IV) iron and oral iron market. For patients suffering from severe anaemia or haemorrhage, blood transfusions are proved to be life-saving. As the cost of blood transfusions is high, there are adverse outcomes of blood transfusion, and due to the questionable efficacy of transfusions the demand for patient blood management can be expected to rise; thus, opening arenas for iron therapies.
The report also provides the Porter’s five forces analysis along with a description of each of the forces and its impact on the market.
Global Intravenous (IV) Iron and Oral Iron - Geographical Analysis
The report includes the market analysis of global intravenous (IV) iron and oral iron market in different regions such as the Americas, APAC, and EMEA. The report outlines the major market share holder in the global intravenous (IV) iron and oral iron market and the market size analysis of all the regions. The intravenous (IV) iron and oral iron market report also provides the market size and forecast of the key countries. The America region is expected to be the largest market for intravenous (IV) iron and oral iron drugs followed by EMEA. US, Canada, and Brazil are the key countries in this region contributing a major chunk of revenue.
Large population of people suffering from CKD, diabetes and undergoing dialysis is going to spur the market for intravenous (IV) iron and oral iron in European nations. Likewise, in APAC region large population of people suffering from diabetes in major countries such as China, Japan, and India is going to propel the demand for intravenous (IV) iron and oral iron drugs. In addition, the increasing number of people undergoing renal replacement therapies in Australia and New Zealand, is expected to boost the market for intravenous (IV) iron and oral iron drugs.
Global Intravenous (IV) Iron and Oral Iron - Market Share and Key Vendors
This market research report profiles the major companies in the global intravenous (IV) iron and oral iron drugs market and also provides the competitive landscape and in-depth profile of key players. Within the report covers the entire market outlook regarding the value chain operating within the market. The major players in the market include
• Actavis
• AMAG Pharmaceuticals
• Cipla
• Indoco Remedies
• Vifor Pharma
The other leading vendors in the global intravenous (IV) iron and oral iron market include Sanofi, Arbro Pharmaceuticals, Solace Biotech, ALDE MEDI IMPEX, American Biocare.
Why Should you buy this report?
The report gives reasonable answers for the following questions which leads you to know the in- depth market analysis of market such as
1. How has the market been performing and what are some of the current changes which are expected to change the landscape in the coming years?
2. What are the various factors that can affect the market and in what way over the next few years?
3. What are the emerging trends and challenges for the market over the next five years?
4. What is the market size and market forecast for each market segment?
5. What is the market size and market forecast for each user type?
6. Which regions are going to have the largest market share and what are the factors propelling the market growth in that region?
7. Which are the key countries and the market size and market forecast in the key countries?
8. Which companies are the key vendors in the market?
9. What are the strategies used by the top vendors, and what are the opportunities to grow?
10. Which companies are the emerging vendors?
CONTENTS
Section 1 Research Methodology
Section 2 Executive Summary
2.1 Key Market Facts
2.2 Geographical Scenario
2.3 Vendors in the Market
Section 3 Report Coverage
3.1 Scope of Study
3.2 Base Year
3.3 Assumptions
Section 4 Market Research Methodology
4.1 Geographical Segmentation
4.2 Vendor Segmentation
4.3 Currency Conversion Rates
Section 5 Introduction
5.1 Iron
5.2 Balance of Iron in Various Stages of body
5.3 Trivia about Iron Deficiency Anemia (IDA)
5.4 Iron Drugs
5.5 Population Requiring Intravenous Iron Supplementation
Section 6 Market Landscape
6.1 Market Overview
6.2 Vendors in the Market
Section 7 Key Excerpts of the Study
Section 8 Key Market Growth Drivers
8.1 Increasing Number of Dialysis Patients
8.2 Growing Diabetic Population Worldwide
8.3 Prevalence of Iron Deficiency
8.4 Growing Incidence of CKD Increases Need for Dialysis
8.5 Assessment of Market Growth Drivers
Section 9 Key Market Challenges
9.1 Alternative to Iron Therapy for Patients Suffering from CKD
9.2 Focus on Healthy Diet and Nutraceuticals
9.3 Biscuits to Replace Iron Pills
9.4 Assessment of Market Challenges
Section 10 Key Market Trends
10.1 Paradigm Shift from Oral to IV Iron Drugs
10.2 Bundled Payment System in US
10.3 Correction of IDA during Pregnancy
Section 11 Key Market Growth Opportunity
11.1 Huge Patient Population Undergoing Dialysis
11.2 PBM
Section 12 Evidence-based Research Studies
Section 13 Global IV and Oral Iron Drug Market by Mode of Delivery
13.1 Oral Delivery of Iron
13.1.1 Ferrous sulfate
13.1.2 Carbonyl iron
13.2 Intravenous (IV) Delivery of Iron
13.2.1 Iron Dextran Complex
13.2.2 Iron Sucrose
13.2.3 Ferric Carboxymaltose
Section 14 Global IV and Oral Iron Drug Market by Therapeutic Area
14.1 Nephrology
14.2 Gynecology and Obstetrics
14.3 Gastroenterology
14.4 Oncology
14.5 Chronic Heart Failures
14.6 PBM
Section 15 IV and Oral Iron Drug Market in the Americas
15.1 Penetration of IV and Oral Iron Drugs Market in the Americas
15.1.1 Penetration of IV and Oral Iron Drugs in the US
15.1.2 Penetration of IV and Oral Iron Drugs in Canada
15.1.3 Penetration of IV and Oral Iron Drugs in Brazil
15.1.4 Penetration of IV and Oral Iron Drugs in Rest of the Americas
Section 16 IV and Oral Iron Market in EMEA
16.1 Penetration of IV and Oral Iron Drugs Market in EMEA
16.2 Penetration of IV and Oral Iron Drugs in Europe
16.2.1 Penetration of IV and Oral Iron Drugs in Germany
16.2.2 Penetration of IV and Oral Iron Drugs in the UK
16.2.3 Penetration of IV and Oral Iron Drugs in France
16.2.4 Penetration of IV and Oral Iron Drugs in Italy
16.2.5 Penetration of IV and Oral Iron Drugs in Spain
16.2.6 Penetration of IV and Oral Iron Drugs in Rest of Europe
16.3 Penetration of IV and Oral Iron Drugs in the Middle East
16.4 Penetration of IV and Oral Iron Drugs in Africa
Section 17 Penetration of IV and Oral Iron Drugs in APAC
17.1 Penetration of IV and Oral Iron Drugs in APAC
17.1.1 Penetration of IV and Oral Iron Drugs in Japan
17.1.2 Penetration of IV and Oral Iron Drugs in China
17.1.3 Penetration of IV and Oral Iron Drugs in India
17.1.4 Penetration of IV and Oral Iron Drugs in Rest of APAC
Section 18 Market Share Analysis
18.1 Market Share Analysis
18.2 Vifor Pharma
18.3 Actavis Inc.
18.4 AMAG Pharmaceuticals Inc.
18.5 Other Leading Players in the Market
18.5.1 Sanofi
18.5.2 Indoco Remedies Ltd.
18.5.3 Cipla Ltd.
18.5.4 Arbro Pharmaceuticals Ltd.
18.5.5 Solace Biotech
18.5.6 ALDE MEDI IMPEX LTD.
18.5.7 American Biocare
Section 19 Key Vendor Analysis
19.1 Vifor Pharma Ltd.
19.1.1 About the Company
19.1.2 Product Offerings
19.1.3 Strengths
19.1.4 Opportunities
19.1.5 Strategy
19.2 AMAG Pharmaceuticals Inc.
19.2.1 About the Company
19.2.2 Product Offerings
19.2.3 Strengths
19.2.4 Opportunities
19.2.5 Strategy
19.3 Actavis Pharma Inc.
19.3.1 About the Company
19.3.2 Product Offerings
19.3.3 Strengths
19.3.4 Opportunities
19.3.5 Strategy
19.4 Indoco Remedies Ltd.
19.4.1 About the Company
19.4.2 Product Offerings
19.4.3 Strengths
19.4.4 Opportunities
19.4.5 Strategy
19.5 Cipla Ltd.
19.5.1 About the Company
19.5.2 Product Offerings
19.5.3 Strengths
19.5.4 Opportunities
19.5.5 Strategy
Section 20 Summary of the Report
Section 21 Appendix
21.1 List of Abbreviations
?
EXHIBITS
Exhibit 1 Segmentation of IV and Oral Iron Drug Market
Exhibit 2 Market Size Calculation - Bottom-up Approach
Exhibit 3 Market Size Calculation - Top-down Approach
Exhibit 4 Currency Conversion Chart
Exhibit 5 Worldwide IV and Oral Iron Drug Market 2015?2021 (US$ million)
Exhibit 6 Diabetic Population across Geographies 2015?2040 (estimated)
Exhibit 7 Assessment of Market Growth Drivers
Exhibit 8 ESAs in the Pipeline
Exhibit 9 Assessment of Market Challenges
Exhibit 10 Number of Dialysis Patients Worldwide, Forecast to 2020
Exhibit 11 Evidence-based Research Studies for IV and Oral Iron Drugs
Exhibit 12 Global IV and Oral Iron Drug Market Share by Mode of Delivery (2015)
Exhibit 13 Global Oral Iron Drug Market 2015?2021 (US$ Million)
Exhibit 14 Global Intravenous (IV) Iron Drug Market 2015?2021 (US$ million)
Exhibit 15 Global IV and Oral Drug Iron Market by Therapeutic Area (2015)
Exhibit 16 Global IV and Oral Iron Drug Market in Nephrology 2015?2021 (US$ million)
Exhibit 17 Prevalence of Anemia in Women in the Age Group of 15?49 years 2015
Exhibit 18 Global IV and Oral Iron Drug Market in Gynecology and Obstetrics 2015?2021 (US$ million)
Exhibit 19 Estimate of Bariatric Surgery Numbers in the US (2011?2015)
Exhibit 20 Global IV and Oral Iron Drug Market in Gastroenterology 2015?2021 (US$ million)
Exhibit 21 Global IV and Oral Iron Drug Market in Oncology 2015?2021 (US$ million)
Exhibit 22 Global IV and Oral Iron Market in Chronic Heart Failures 2015?2021 (US$ million)
Exhibit 23 Global IV and Oral Iron Drug Market in PBM 2015?2021 (US$ million)
Exhibit 24 IV and Oral Iron Drug Market in the Americas 2015?2021 (US$ million)
Exhibit 25 Market Share of IV and Oral Iron Market in the Americas by Country (2015)
Exhibit 26 IV and Oral Iron Market in the US 2015?2021 (US$ million)
Exhibit 27 IV and Oral Iron Drug Market in Canada 2015?2021 (US$ million)
Exhibit 28 IV and Oral Iron Market in Brazil 2015?2021 (US$ million)
Exhibit 29 Diabetes in Mexico 2015
Exhibit 30 IV and Oral Iron Market in Rest of the Americas 2015?2021 (US$ million)
Exhibit 31 IV and Oral Iron Market in EMEA 2015?2021 (US$ million)
Exhibit 32 Market Share of IV and Oral Iron Drug in EMEA by Region (2015)
Exhibit 33 IV and Oral Iron Market in Europe 2015?2021 (US$ Million)
Exhibit 34 Number of ESRD Patients by Therapy in EU
Exhibit 35 Market Share of IV and Oral Iron Market in Europe in EU5 Countries (2015)
Exhibit 36 Diabetes in Germany 2015
Exhibit 37 IV and Oral Iron Market in Germany 2015?2021 (US$ million)
Exhibit 38 People having Diabetes in the UK 2016
Exhibit 39 Price Differential between OFP and IV Therapies (drug cost only)
Exhibit 40 IV and Oral Iron Drug Market in the UK 2015?2021 (US$ million)
Exhibit 41 Diabetes in France 2015
Exhibit 42 IV and Oral Iron Market in France 2015?2021 (US$ million)
Exhibit 43 Diabetes in Italy 2015
Exhibit 44 IV and Oral Iron Market in Italy 2015?2021 (US$ million)
Exhibit 45 Diabetes in Spain 2015
Exhibit 46 IV and Oral Iron Market in Spain 2015?2021 (US$ million)
Exhibit 47 Diabetes in the Netherlands 2015
Exhibit 48 Diabetes in Sweden 2015
Exhibit 49 Diabetes in Switzerland 2015
Exhibit 50 IV and Oral Iron Market in RoE 2015?2021 (US$ million)
Exhibit 51 IV and Oral Iron Drug Market in the Middle East 2015?2021 (US$ million)
Exhibit 52 IV and Oral Iron Market in Africa 2015?2021 (US$ million)
Exhibit 53 IV and Oral Iron Market in APAC 2015?2021 (US$ Million)
Exhibit 54 Market Share of IV and Oral Iron Market in APAC by Country (2015)
Exhibit 55 Diabetes in Japan 2015
Exhibit 56 IV and Oral Iron Market in Japan 2015?2021 (US$ million)
Exhibit 57 Diabetes in China 2015
Exhibit 58 IV and Oral Iron Market in China 2015?2021 (US$ million)
Exhibit 59 IV and Oral Iron Market in India 2015?2021 (US$ million)
Exhibit 60 Prevalence (pmp) of Renal Replacement Therapy, 1995?2014
Exhibit 61 Prevalence (pmp) of Renal Replacement Therapy by Age 2014
Exhibit 62 Diabetes in Republic of Korea 2015
Exhibit 63 IV and Oral Iron Market in Rest of APAC 2015?2021 (US$ million)
Exhibit 64 Market Share of Vifor Pharma in IV and Oral Iron 2015
Exhibit 65 Market Share of Vifor Pharma in Oral Iron 2015
Exhibit 66 Market Share of Vifor Pharma in IV Iron 2015
Exhibit 67 Sales of Major Products by Vifor Pharma (US$ Million)
Exhibit 68 Sales of Major Products by AMAG Pharmaceuticals (US$ million)
Exhibit 69 Descriptive Summary of the Global IV and Oral Iron Drug Market
Exhibit 70 Summary of Global IV and Oral Iron Drug Market by Mode of Delivery 2015?2021 (US$ million)
Exhibit 71 Summary of Global IV and Oral Iron Market by Therapeutic Area 2015?2021 (US$ million)
Exhibit 72 Summary of Global IV and Oral Iron Market by Geography 2015?2021 (US$ million)
Exhibit 73 Summary of IV and Oral Iron Market in Americas by Country 2015?2021 (US$ million)
Exhibit 74 Summary of IV and Oral Iron Market in EMEA by Country 2015?2021 (US$ million)
Exhibit 75 Summary of IV and Oral Iron Market in APAC by Country 2015?2021 (US$ million)
